OBJECTIVES: The purpose of this study was to evaluate the impact of inappropriate antimicrobial therapy on the outcome of patients with hospital-acquired pneumonia (HAP) caused by Acinetobacter baumannii. METHODS: All cases of HAP caused by A. baumannii from January 2000 to March 2006 at the Samsung Medical Center (Seoul, Korea) were analyzed retrospectively. RESULTS: A total of 116 patients with clinically significant Acinetobacter HAP were enrolled. Among the A. baumannii isolates, 60.3% showed multi-drug resistance (MDR), 16.4% were found to have imipenem resistance, and 15.5% had pan-drug resistance (PDR). The mean APACHE II score of the patients was 22.3 +/- 7.9. The overall in-hospital and pneumonia-related mortality rates were 47.4% and 37.9%, respectively. The univariate analysis showed that the factors associated with pneumonia-related mortality were: MDR, PDR, high APACHE II score, inappropriate empirical antimicrobial therapy, and inappropriate definitive antimicrobial treatment (All p < 0.05). Among these, a high APACHE II score and inappropriate definitive antimicrobial therapy were found to be independent factors associated with a high mortality, after adjustment for other variables. CONCLUSIONS: The appropriate definitive antimicrobial therapy should be provided in patients with HAP caused by A. baumannii. Copyright 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
OBJECTIVES: The purpose of this study was to evaluate the impact of inappropriate antimicrobial therapy on the outcome of patients with hospital-acquired pneumonia (HAP) caused by Acinetobacter baumannii. METHODS: All cases of HAP caused by A. baumannii from January 2000 to March 2006 at the Samsung Medical Center (Seoul, Korea) were analyzed retrospectively. RESULTS: A total of 116 patients with clinically significant Acinetobacter HAP were enrolled. Among the A. baumannii isolates, 60.3% showed multi-drug resistance (MDR), 16.4% were found to have imipenem resistance, and 15.5% had pan-drug resistance (PDR). The mean APACHE II score of the patients was 22.3 +/- 7.9. The overall in-hospital and pneumonia-related mortality rates were 47.4% and 37.9%, respectively. The univariate analysis showed that the factors associated with pneumonia-related mortality were: MDR, PDR, high APACHE II score, inappropriate empirical antimicrobial therapy, and inappropriate definitive antimicrobial treatment (All p < 0.05). Among these, a high APACHE II score and inappropriate definitive antimicrobial therapy were found to be independent factors associated with a high mortality, after adjustment for other variables. CONCLUSIONS: The appropriate definitive antimicrobial therapy should be provided in patients with HAP caused by A. baumannii. Copyright 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
Authors: Sujata M Bhavnani; Christopher M Rubino; Jeffrey P Hammel; Alan Forrest; Nathalie Dartois; C Angel Cooper; Joan Korth-Bradley; Paul G Ambrose Journal: Antimicrob Agents Chemother Date: 2011-12-05 Impact factor: 5.191
Authors: X Wang; L Zhang; A Sun; X Yang; W Sang; Y Jiang; J Cheng; J Wang; M Zhou; B Chen; J Ouyang Journal: Eur J Clin Microbiol Infect Dis Date: 2017-01-18 Impact factor: 3.267
Authors: Youn Jeong Kim; Sang Il Kim; Kyung-Wook Hong; Yang Ree Kim; Yeon Joon Park; Moon-Won Kang Journal: J Korean Med Sci Date: 2012-04-25 Impact factor: 2.153